Chiquita Brooks-LaSure, CMS director (Photo by Caroline Brehman/CQ Roll Call via AP Images)
Inflation rebates: CMS lays the ground rules for pharma compliance
The Centers for Medicare and Medicaid Services this afternoon unveiled its first tranche of guidance on how drug companies will comply with new mandatory rebates …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
